Livent Corporation (LTHM)
NYSE: LTHM
· Real-Time Price · USD
16.51
-1.54 (-8.53%)
At close: Jan 03, 2024, 10:00 PM
Livent Revenue Breakdown
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|
| Butyllithium Revenue | 277.7M | 105.4M | 87.1M | 99.9M | 99M |
| Butyllithium Revenue Growth | +163.47% | +21.01% | -12.81% | +0.91% | n/a |
| High Purity Lithium Metal and Other Specialty Compounds Revenue | 50.9M | 36.9M | 31.7M | 52.4M | 62.5M |
| High Purity Lithium Metal and Other Specialty Compounds Revenue Growth | +37.94% | +16.40% | -39.50% | -16.16% | n/a |
| Lithium Carbonate & Lithium Chloride Revenue | 69.1M | 70.1M | 11.9M | 22.3M | 58.3M |
| Lithium Carbonate & Lithium Chloride Revenue Growth | -1.43% | +489.08% | -46.64% | -61.75% | n/a |
| Lithium Hydroxide Revenue | 415.5M | 208M | 157.5M | 213.8M | 222.7M |
| Lithium Hydroxide Revenue Growth | +99.76% | +32.06% | -26.33% | -4.00% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|
| Asia Pacific Revenue | 566.5M | 296.8M | 185.5M | 252.2M | 281.6M |
| Asia Pacific Revenue Growth | +90.87% | +60.00% | -26.45% | -10.44% | n/a |
| China Revenue | 304.9M | 160M | 55.3M | 53.2M | 118.6M |
| China Revenue Growth | +90.56% | +189.33% | +3.95% | -55.14% | n/a |
| Emea Revenue | 98.1M | 62.2M | 49.2M | 59M | 74.5M |
| Emea Revenue Growth | +57.72% | +26.42% | -16.61% | -20.81% | n/a |
| Japan Revenue | 167.6M | 75.1M | 97.7M | 160.4M | 116.5M |
| Japan Revenue Growth | +123.17% | -23.13% | -39.09% | +37.68% | n/a |
| Latin America Revenue | 2.9M | n/a | 200K | 1M | 2M |
| Latin America Revenue Growth | n/a | -100.00% | -80.00% | -50.00% | n/a |
| North America Revenue | 145.7M | 61.4M | 53.3M | 76.2M | 84.4M |
| North America Revenue Growth | +137.30% | +15.20% | -30.05% | -9.72% | n/a |
| United States Revenue | 139.1M | 59.9M | 52.6M | 75.2M | 82.4M |
| United States Revenue Growth | +132.22% | +13.88% | -30.05% | -8.74% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 13.2M | 17.6M | 16.3M | 14.6M | 15M | 13.8M | 11.8M | 16.4M | 11.8M | 11.7M | 10.6M | 11.6M | 10M | 10.3M | 10.8M | 12.2M | 10.2M | 11.1M | 10.8M | 15.3M | 10.3M | 9.4M | 8.7M | 9.9M | 8M |
| Selling, General, and Administrative Revenue Growth | -25.00% | +7.98% | +11.64% | -2.67% | +8.70% | +16.95% | -28.05% | +38.98% | +0.85% | +10.38% | -8.62% | +16.00% | -2.91% | -4.63% | -11.48% | +19.61% | -8.11% | +2.78% | -29.41% | +48.54% | +9.57% | +8.05% | -12.12% | +23.75% | n/a |
| Research and Development Revenue | 1.3M | 1M | 1M | 1.3M | 900K | 800K | 900K | 800K | 800K | 700K | 700K | 900K | 1M | 800K | 1M | 800K | 900K | 800K | 800K | 900K | 900K | 1M | 1M | 800K | 900K |
| Research and Development Revenue Growth | +30.00% | 0.00% | -23.08% | +44.44% | +12.50% | -11.11% | +12.50% | 0.00% | +14.29% | 0.00% | -22.22% | -10.00% | +25.00% | -20.00% | +25.00% | -11.11% | +12.50% | 0.00% | -11.11% | 0.00% | -10.00% | 0.00% | +25.00% | -11.11% | n/a |